Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma

NCT03633734 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma Metastatic
Chemotherapy Effect

Interventions

DRUG: Sequential Treatment

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University